These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30697254)

  • 1. Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy.
    Jäger B; Piackova E; Haller PM; Andric T; Kahl B; Christ G; Geppert A; Wojta J; Huber K
    Arch Med Sci; 2019 Jan; 15(1):65-71. PubMed ID: 30697254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Lipids, Mean Platelet Volume, and the Severity of Coronary Artery Disease Among Chinese Adults: A Mediation Analysis.
    Yao Y; Li X; Wang Z; Ji Q; Xu Q; Yan Y; Lv Q
    Front Cardiovasc Med; 2022; 9():753171. PubMed ID: 35174229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
    Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.
    Barbieri L; Verdoia M; Pergolini P; Nardin M; Rolla R; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Apr; 26(4):352-8. PubMed ID: 26857781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapy.
    Nardin M; Verdoia M; Gioscia R; Negro F; De Luca G
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1276-1285. PubMed ID: 33549433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Barbieri L; Pergolini P; Verdoia M; Rolla R; Nardin M; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Vascul Pharmacol; 2016 Apr; 79():11-15. PubMed ID: 26518440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Sartori C; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Platelets; 2016 Sep; 27(6):576-82. PubMed ID: 27540959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Higaki T; Kurisu S; Watanabe N; Ikenaga H; Shimonaga T; Iwasaki T; Mitsuba N; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    Heart Vessels; 2016 Mar; 31(3):269-74. PubMed ID: 25381477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean platelet volume and platelet distribution width levels in patients with mild psoriasis vulgaris with metabolic syndrome.
    Korkmaz S
    Postepy Dermatol Alergol; 2018 Aug; 35(4):367-371. PubMed ID: 30206448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; Luca GD;
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):143-50. PubMed ID: 26868495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study.
    Qiu W; Chen J; Huang X; Guo J
    Lipids Health Dis; 2020 Jul; 19(1):163. PubMed ID: 32631347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease.
    Nardin M; Verdoia M; Barbieri L; De Luca G;
    Platelets; 2019; 30(5):615-623. PubMed ID: 30047817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy.
    Golukhova EZ; Grigoryan MV; Ryabinina MN; Bulaeva NI; Serebruany VL
    Cardiology; 2018; 139(2):132-136. PubMed ID: 29334682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators--A pilot study.
    Kucera M; Balaz D; Kruzliak P; Ciccocioppo R; Oravec S; Rodrigo L; Zulli A; Hirnerova E; Sabaka P; Komornikova A; Sabo J; Slezak P; Gaspar L
    Clin Biochem; 2015 Jun; 48(9):557-61. PubMed ID: 25727667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
    Verdoia M; Pergolini P; Barbieri L; Rolla R; Nardin M; Negro F; Suryapranata H; De Luca G;
    Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of platelet distribution width on the extent and long-term outcome of patients with stable coronary artery disease post percutaneous coronary intervention].
    Jiang P; Song Y; Xu JJ; Ma YL; Tang XF; Yao Y; Jiang L; Wang HH; Zhang X; Diao XL; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Oct; 45(10):862-866. PubMed ID: 29081176
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation.
    Verdoia M; Pergolini P; Nardin M; Rolla R; Barbieri L; Marino P; Carriero A; Suryapranata H; De Luca G;
    J Cardiol; 2019 Mar; 73(3):198-203. PubMed ID: 30522897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.